Benzinga··Glancy Prongay Wolke & Rotter LlpADMA Biologics Faces Securities Fraud Probe Over Channel Stuffing Allegations
ADMA Biologics faces securities fraud investigation for alleged channel stuffing, resulting in 29.1% stock decline to $9.63 per share.
ADMAsecurities fraudstock decline